Published in J Exp Med on January 07, 2002
The transcription factor PU.1 is required for the development of IL-9-producing T cells and allergic inflammation. Nat Immunol (2010) 3.97
Functions of T cells in asthma: more than just T(H)2 cells. Nat Rev Immunol (2010) 2.62
IL-9 governs allergen-induced mast cell numbers in the lung and chronic remodeling of the airways. Am J Respir Crit Care Med (2010) 2.36
A brief history of IL-9. J Immunol (2011) 2.27
Tolerance induced by inhaled antigen involves CD4(+) T cells expressing membrane-bound TGF-beta and FOXP3. J Clin Invest (2004) 2.20
Osteopontin has a crucial role in allergic airway disease through regulation of dendritic cell subsets. Nat Med (2007) 2.08
Therapeutic targeting of Janus kinases. Immunol Rev (2008) 2.03
Th9 and allergic disease. Immunology (2009) 1.97
Importance of cytokines in murine allergic airway disease and human asthma. J Immunol (2010) 1.86
Mouse models of allergic asthma: acute and chronic allergen challenge. Dis Model Mech (2008) 1.86
IL-9-mediated survival of type 2 innate lymphoid cells promotes damage control in helminth-induced lung inflammation. J Exp Med (2013) 1.75
Resolution of allergic inflammation and airway hyperreactivity is dependent upon disruption of the T1/ST2-IL-33 pathway. Am J Respir Crit Care Med (2009) 1.72
Regulation of airway mucin gene expression. Annu Rev Physiol (2008) 1.53
Antigen-induced increases in pulmonary mast cell progenitor numbers depend on IL-9 and CD1d-restricted NKT cells. J Immunol (2009) 1.28
T-cell biology in aging, with a focus on lung disease. J Gerontol A Biol Sci Med Sci (2012) 1.21
Targeting the Jak/STAT pathway for immunosuppression. Ann Rheum Dis (2004) 1.16
Siglec-E is a negative regulator of acute pulmonary neutrophil inflammation and suppresses CD11b β2-integrin-dependent signaling. Blood (2013) 1.13
The many lives of IL-9: a question of survival? Nat Immunol (2012) 1.11
Differential regulation of MUC5AC/Muc5ac and hCLCA-1/mGob-5 expression in airway epithelium. Am J Respir Cell Mol Biol (2005) 1.10
Preclinical development of CAT-354, an IL-13 neutralizing antibody, for the treatment of severe uncontrolled asthma. Br J Pharmacol (2012) 1.10
Role of innate lymphocytes in infection and inflammation. Front Immunol (2012) 1.08
Th2-driven, allergen-induced airway inflammation is reduced after treatment with anti-Tim-3 antibody in vivo. J Exp Med (2007) 1.08
Emerging roles of T helper subsets in the pathogenesis of asthma. Immunol Invest (2010) 1.03
IL-9 is important for T-cell activation and differentiation in autoimmune inflammation of the central nervous system. Eur J Immunol (2011) 1.01
The unique features of Th9 cells and their products. Crit Rev Immunol (2012) 1.00
Asthma: T-bet--a master controller? Curr Biol (2002) 0.96
Tim1 and Tim3 are not essential for experimental allergic asthma. Clin Exp Allergy (2011) 0.88
Chronic allergen challenge induces bronchial mast cell accumulation in BALB/c but not C57BL/6 mice and is independent of IL-9. Immunogenetics (2010) 0.88
IL-9 and IL-13 induce mucous cell metaplasia that is reduced by IFN-gamma in a Bax-mediated pathway. Am J Respir Cell Mol Biol (2007) 0.88
Identification of antigenic epitopes on human allergens: studies with HLA transgenic mice. Environ Health Perspect (2003) 0.86
Autophagy is essential for ultrafine particle-induced inflammation and mucus hyperproduction in airway epithelium. Autophagy (2016) 0.86
Airway allergen exposure stimulates bone marrow eosinophilia partly via IL-9. Respir Res (2005) 0.85
Distinct chemokine receptor axes regulate Th9 cell trafficking to allergic and autoimmune inflammatory sites. J Immunol (2013) 0.84
Prolonged recurrence-free survival following OK432-stimulated dendritic cell transfer into hepatocellular carcinoma during transarterial embolization. Clin Exp Immunol (2010) 0.84
IL-9-producing cells in the development of IgE-mediated food allergy. Semin Immunopathol (2016) 0.84
Mucin production and mucous cell metaplasia in otitis media. Int J Otolaryngol (2012) 0.83
Distinct different expression of Th17 and Th9 cells in coxsackie virus B3-induced mice viral myocarditis. Virol J (2011) 0.82
Dexamethasone inhibits IL-9 production by human T cells. J Inflamm (Lond) (2005) 0.79
Amelioration of ovalbumin-induced allergic airway disease following Der p 1 peptide immunotherapy is not associated with induction of IL-35. Mucosal Immunol (2013) 0.79
A crucial role for β2 integrins in podosome formation, dynamics and Toll-like-receptor-signaled disassembly in dendritic cells. J Cell Sci (2014) 0.78
Cystatin F Ensures Eosinophil Survival by Regulating Granule Biogenesis. Immunity (2016) 0.77
BATF Modulates the Th2 Locus Control Region and Regulates CD4+ T Cell Fate during Antihelminth Immunity. J Immunol (2016) 0.75
From bench to bedside: Therapeutic potential of interleukin-9 in the treatment of asthma. Exp Ther Med (2017) 0.75
Absence of the common gamma chain (γ(c)), a critical component of the Type I IL-4 receptor, increases the severity of allergic lung inflammation. PLoS One (2013) 0.75
Interleukin-13: central mediator of allergic asthma. Science (1998) 14.05
Requirement for IL-13 independently of IL-4 in experimental asthma. Science (1998) 10.76
Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. J Clin Invest (1999) 8.38
Noninvasive measurement of airway responsiveness in allergic mice using barometric plethysmography. Am J Respir Crit Care Med (1997) 7.12
Interleukin 4, but not interleukin 5 or eosinophils, is required in a murine model of acute airway hyperreactivity. J Exp Med (1996) 4.54
Genetic susceptibility to asthma--bronchial hyperresponsiveness coinherited with a major gene for atopy. N Engl J Med (1995) 2.98
Eosinophil recruitment to the lung in a murine model of allergic inflammation. The role of T cells, chemokines, and adhesion receptors. J Clin Invest (1996) 2.92
Crucial role of the interleukin 1 receptor family member T1/ST2 in T helper cell type 2-mediated lung mucosal immune responses. J Exp Med (1999) 2.92
IL-9-deficient mice establish fundamental roles for IL-9 in pulmonary mastocytosis and goblet cell hyperplasia but not T cell development. Immunity (2000) 2.74
Expression of interleukin 9 in the lungs of transgenic mice causes airway inflammation, mast cell hyperplasia, and bronchial hyperresponsiveness. J Exp Med (1998) 2.55
Interleukin-9 upregulates mucus expression in the airways. Am J Respir Cell Mol Biol (2000) 2.25
New insights into the role of cytokines in asthma. J Clin Pathol (2001) 2.09
Interleukin 9: a candidate gene for asthma. Proc Natl Acad Sci U S A (1997) 1.84
IL-9 and its receptor in allergic and nonallergic lung disease: increased expression in asthma. J Allergy Clin Immunol (2000) 1.75
Cloning and characterization of a cDNA for a new mouse T cell growth factor (P40). J Exp Med (1989) 1.73
Allergen-induced IL-9 directly stimulates mucin transcription in respiratory epithelial cells. J Clin Invest (1999) 1.67
Interleukin-9 promotes allergen-induced eosinophilic inflammation and airway hyperresponsiveness in transgenic mice. Am J Respir Cell Mol Biol (1998) 1.60
Effects of Th2 cytokines on chemokine expression in the lung: IL-13 potently induces eotaxin expression by airway epithelial cells. J Immunol (1999) 1.59
IL-13 induces airways hyperreactivity independently of the IL-4R alpha chain in the allergic lung. J Immunol (2001) 1.41
Interleukin-9 potentiates the interleukin-4-induced IgE and IgG1 release from murine B lymphocytes. Immunology (1993) 1.35
Interleukin 9-induced in vivo expansion of the B-1 lymphocyte population. J Exp Med (1999) 1.23
IL-9 induces chemokine expression in lung epithelial cells and baseline airway eosinophilia in transgenic mice. Eur J Immunol (1999) 1.22
IL-13 in allergy: home at last. Curr Opin Immunol (1999) 1.17
Interleukin-9 enhances interleukin-5 receptor expression, differentiation, and survival of human eosinophils. Blood (2000) 1.16
Resolution of bronchial hyperresponsiveness and pulmonary inflammation is associated with IL-3 and tissue leukocyte apoptosis. J Immunol (2001) 1.12
Lung mucus: a clinician's view. Eur Respir J (1997) 1.11
Interleukin 9 promotes influx and local maturation of eosinophils. Blood (2001) 1.09
IL-9 expression by human eosinophils: regulation by IL-1beta and TNF-alpha. J Allergy Clin Immunol (2000) 1.03
Interleukin 9 and its receptor: an overview of structure and function. Int Rev Immunol (1998) 1.01
Murine interleukin 9 stimulates the proliferation of mouse erythroid progenitor cells and favors the erythroid differentiation of multipotent FDCP-mix cells. Exp Hematol (1992) 0.82
A critical role for eosinophils in allergic airways remodeling. Science (2004) 5.53
Resolution of airway inflammation and hyperreactivity after in vivo transfer of CD4+CD25+ regulatory T cells is interleukin 10 dependent. J Exp Med (2005) 3.48
Recent developments in the transcriptional regulation of cytolytic effector cells. Nat Rev Immunol (2004) 3.14
The Th17 pathway in cystic fibrosis lung disease. Am J Respir Crit Care Med (2011) 2.87
IL-4 induces characteristic Th2 responses even in the combined absence of IL-5, IL-9, and IL-13. Immunity (2002) 2.83
IL-33-responsive lineage- CD25+ CD44(hi) lymphoid cells mediate innate type 2 immunity and allergic inflammation in the lungs. J Immunol (2011) 2.54
Mouse models of rhinovirus-induced disease and exacerbation of allergic airway inflammation. Nat Med (2008) 2.44
Interleukin-33 attenuates sepsis by enhancing neutrophil influx to the site of infection. Nat Med (2010) 2.38
IL-9 governs allergen-induced mast cell numbers in the lung and chronic remodeling of the airways. Am J Respir Crit Care Med (2010) 2.36
Manipulation of allergen-induced airway remodeling by treatment with anti-TGF-beta antibody: effect on the Smad signaling pathway. J Immunol (2005) 2.22
Osteopontin has a crucial role in allergic airway disease through regulation of dendritic cell subsets. Nat Med (2007) 2.08
Modular analysis of peripheral blood gene expression in rheumatoid arthritis captures reproducible gene expression changes in tumor necrosis factor responders. Arthritis Rheumatol (2015) 2.08
Activin A and TGF-β promote T(H)9 cell-mediated pulmonary allergic pathology. J Allergy Clin Immunol (2012) 1.98
Uncoupling of GTP hydrolysis from eIF6 release on the ribosome causes Shwachman-Diamond syndrome. Genes Dev (2011) 1.89
Of flies, mice and men: a systematic approach to understanding the early life origins of chronic lung disease. Thorax (2012) 1.88
The transcription factors T-bet and GATA-3 control alternative pathways of T-cell differentiation through a shared set of target genes. Proc Natl Acad Sci U S A (2009) 1.86
Orchestrating house dust mite-associated allergy in the lung. Trends Immunol (2011) 1.86
Development of allergic airway disease in mice following antibiotic therapy and fungal microbiota increase: role of host genetics, antigen, and interleukin-13. Infect Immun (2005) 1.85
Interleukin-33 induces protective effects in adipose tissue inflammation during obesity in mice. Circ Res (2010) 1.80
SIGN-R1 contributes to protection against lethal pneumococcal infection in mice. J Exp Med (2004) 1.73
Peptide immunotherapy in allergic asthma generates IL-10-dependent immunological tolerance associated with linked epitope suppression. J Exp Med (2009) 1.73
Resolution of allergic inflammation and airway hyperreactivity is dependent upon disruption of the T1/ST2-IL-33 pathway. Am J Respir Crit Care Med (2009) 1.72
Helminth infection protects mice from anaphylaxis via IL-10-producing B cells. J Immunol (2004) 1.57
CD4+CD25+ regulatory T cells reverse established allergic airway inflammation and prevent airway remodeling. J Allergy Clin Immunol (2008) 1.51
Matrix metalloproteinase-9 deficiency results in enhanced allergen-induced airway inflammation. J Immunol (2004) 1.49
Pediatric severe asthma is characterized by eosinophilia and remodeling without T(H)2 cytokines. J Allergy Clin Immunol (2012) 1.45
IL-25 drives remodelling in allergic airways disease induced by house dust mite. Thorax (2012) 1.26
Promising bone-related therapeutic targets for rheumatoid arthritis. Nat Rev Rheumatol (2009) 1.25
Chronic inflammation and asthma. Mutat Res (2009) 1.22
A plasmablast biomarker for nonresponse to antibody therapy to CD20 in rheumatoid arthritis. Sci Transl Med (2011) 1.20
Phosphatidylethanolamine-esterified eicosanoids in the mouse: tissue localization and inflammation-dependent formation in Th-2 disease. J Biol Chem (2009) 1.18
Th2 activities induced during virgin T cell priming in the absence of IL-4, IL-13, and B cells. J Immunol (2002) 1.16
Synovial phenotypes in rheumatoid arthritis correlate with response to biologic therapeutics. Arthritis Res Ther (2014) 1.15
Resolution of allergic airway inflammation and airway hyperreactivity is mediated by IL-17-producing {gamma}{delta}T cells. Am J Respir Crit Care Med (2010) 1.15
T-bet regulates metastasis rate in a murine model of primary prostate cancer. Cancer Res (2004) 1.14
Overexpression of Smad2 drives house dust mite-mediated airway remodeling and airway hyperresponsiveness via activin and IL-25. Am J Respir Crit Care Med (2010) 1.14
IL-33 promotes airway remodeling in pediatric patients with severe steroid-resistant asthma. J Allergy Clin Immunol (2013) 1.14
Accelerated prion disease in the absence of interleukin-10. J Virol (2004) 1.10
Association of endogenous anti-interferon-α autoantibodies with decreased interferon-pathway and disease activity in patients with systemic lupus erythematosus. Arthritis Rheum (2011) 1.08
Th2-driven, allergen-induced airway inflammation is reduced after treatment with anti-Tim-3 antibody in vivo. J Exp Med (2007) 1.08
Activin and transforming growth factor-beta signaling pathways are activated after allergen challenge in mild asthma. J Allergy Clin Immunol (2009) 1.07
Pathophysiological features of asthma develop in parallel in house dust mite-exposed neonatal mice. Am J Respir Cell Mol Biol (2009) 1.06
Activin-A induces regulatory T cells that suppress T helper cell immune responses and protect from allergic airway disease. J Exp Med (2009) 1.06
CXCR2 mediates the recruitment of endothelial progenitor cells during allergic airways remodeling. Stem Cells (2009) 1.05
CC chemokine ligand 1 promotes recruitment of eosinophils but not Th2 cells during the development of allergic airways disease. J Immunol (2003) 1.04
Bone morphogenetic protein (BMP)-4 and BMP-7 regulate differentially transforming growth factor (TGF)-beta1 in normal human lung fibroblasts (NHLF). Respir Res (2010) 1.01
Inflammation and autoantibody markers identify rheumatoid arthritis patients with enhanced clinical benefit following rituximab treatment. Arthritis Rheum (2011) 1.01
Distal regions of the human IFNG locus direct cell type-specific expression. J Immunol (2010) 0.99
Evaluation of heterophilic antibody blocking agents in reducing false positive interference in immunoassays for IL-17AA, IL-17FF, and IL-17AF. J Immunol Methods (2010) 0.99
CCR4 in human allergen-induced late responses in the skin and lung. Eur J Immunol (2002) 0.99
Nonredundant role of CCRL2 in lung dendritic cell trafficking. Blood (2010) 0.98
Interleukin-4 (IL-4) and IL-10 collude in vaccine failure for novel exacerbatory antigens in murine Leishmania major infection. Infect Immun (2005) 0.97
CCR4 blockade does not inhibit allergic airways inflammation. J Leukoc Biol (2003) 0.97
Asthma: T-bet--a master controller? Curr Biol (2002) 0.96
Automation of large scale transient protein expression in mammalian cells. J Struct Biol (2011) 0.95
A novel immunoglobulin superfamily receptor (19A) related to CD2 is expressed on activated lymphocytes and promotes homotypic B-cell adhesion. Biochem J (2002) 0.94
Novel keto-phospholipids are generated by monocytes and macrophages, detected in cystic fibrosis, and activate peroxisome proliferator-activated receptor-γ. J Biol Chem (2012) 0.92
Endogenous IL-13 plays a crucial role in liver granuloma maturation during Leishmania donovani infection, independent of IL-4Rα-responsive macrophages and neutrophils. J Infect Dis (2011) 0.89
Lymphotoxin-alphabeta heterotrimers are cleaved by metalloproteinases and contribute to synovitis in rheumatoid arthritis. Cytokine (2010) 0.89
Interleukin-9 promotes eosinophilic rejection of mouse heart allografts. Transplantation (2003) 0.89
Adenoid-derived TH2 cells reactive to allergen and recall antigen express CC chemokine receptor 4. J Allergy Clin Immunol (2003) 0.88
MTRX1011A, a humanized anti-CD4 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: a phase I randomized, double-blind, placebo-controlled study incorporating pharmacodynamic biomarker assessments. Arthritis Res Ther (2011) 0.85
CXCR1+CD4+ T cells in human allergic disease. J Immunol (2004) 0.83
Eosinophils in the pathogenesis of paediatric severe asthma. Curr Opin Allergy Clin Immunol (2014) 0.82
Innate responsiveness of CD8 memory T-cell populations nonspecifically inhibits allergic sensitization. J Allergy Clin Immunol (2008) 0.81
Pretreatment synovial transcriptional profile is associated with early and late clinical response in rheumatoid arthritis patients treated with rituximab. Ann Rheum Dis (2012) 0.79
Dust mites' dirty dealings in the lung. Nat Med (2009) 0.79
Lung macrophages contribute to house dust mite driven airway remodeling via HIF-1α. PLoS One (2013) 0.78
Impaired basophil induction leads to an age-dependent innate defect in type 2 immunity during helminth infection in mice. J Immunol (2011) 0.78
Recording information on protein complexes in an information management system. J Struct Biol (2011) 0.77
Efficacy and safety of pateclizumab (anti-lymphotoxin-α) compared to adalimumab in rheumatoid arthritis: a head-to-head phase 2 randomized controlled study (The ALTARA Study). Arthritis Res Ther (2014) 0.77